| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/03/2003 | US20030125290 Cancer treatment with a synthetic sequences |
| 07/03/2003 | US20030125288 PI3K - regulatory subunit homology |
| 07/03/2003 | US20030125287 Antisense oligonucleotides and methods to induce tumor cell death |
| 07/03/2003 | US20030125286 Transcriptional silencer protein NRF |
| 07/03/2003 | US20030125282 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER) |
| 07/03/2003 | US20030125281 Compositions and processes using siRNA, amphipathic compounds and polycations |
| 07/03/2003 | US20030125280 Tissue specific and target RNA-specific ribozymes as antimicrobial therapeutics against microbial pathogens |
| 07/03/2003 | US20030125279 Single-stranded, dumbbell-shaped DNA as immunostimulants, immunomodulators |
| 07/03/2003 | US20030125277 Antisense modulation of activating transcription factor 3 expression |
| 07/03/2003 | US20030125276 Antisense modulation of thyroid hormone receptor interactor 6 expression |
| 07/03/2003 | US20030125275 Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
| 07/03/2003 | US20030125274 Gene expression inhibition, treating brain disorders such as Alzheimer's disease, Down syndrome, schizophrenia, nervous system disorders |
| 07/03/2003 | US20030125273 Antisense modulation of MHC class II transactivator expression |
| 07/03/2003 | US20030125272 Gene expression inhibition by antisense oligonucleotides or polynucleotides; immunology |
| 07/03/2003 | US20030125271 Antisense modulation of vitamin D nuclear receptor expression |
| 07/03/2003 | US20030125270 Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection |
| 07/03/2003 | US20030125263 Nucleic acid ligand complexes |
| 07/03/2003 | US20030125248 Novel bone mineralization proteins, DNA, vectors expression systems |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030125242 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 07/03/2003 | US20030125241 Oligonucleotides for treatment of infectious diseases and disorders caused by viruses, bacteria, protozoa or fungi. Administration of an LNA-modified oligonucleotide modulates expression of a targeted gene associated with the replication |
| 07/03/2003 | US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment |
| 07/03/2003 | US20030125232 Stabilized proteins with engineered disulfide bonds |
| 07/03/2003 | US20030124741 Serine substituted gold inserted apoferritin; transport proteins; for use in producing semiconductors |
| 07/03/2003 | US20030124737 Human chorionic gonadotropin (hCG); cancer diagnosis; antitumor agents; gestational trophoblast diseases |
| 07/03/2003 | US20030124725 Genetrating genomic rearangements in oncogenes; antitumor agents; cancer diagnosis |
| 07/03/2003 | US20030124724 Genetically engineering plants to produce starch with increased amylopectin concentration; auxins; antisense agents; animal feeds; cosmetics; papermaking |
| 07/03/2003 | US20030124723 Use of a nuclease inhibitor or interleukin-10 (IL-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 07/03/2003 | US20030124718 Cytolytic T lymphocyte (CTL); viricides; particle acceleration apparatus |
| 07/03/2003 | US20030124716 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| 07/03/2003 | US20030124708 Modification of virus tropism and host range by viral genome shuffling |
| 07/03/2003 | US20030124707 Acetamidases for use as reporter gene in cell transformations; homologous recombination; gene replacement therapy |
| 07/03/2003 | US20030124704 Neuroprotectants; inhibition of axonal growth; antitumor agents |
| 07/03/2003 | US20030124701 Biocatalyst for use in chemical reactions associated with hydrolysis of triglycerides, esterfication and ester interchange; food processing; lipoproteins |
| 07/03/2003 | US20030124700 Penicillium hydrolases for use in preparation of animal feeds |
| 07/03/2003 | US20030124697 Enzymatic protein for use in preparation of pantothenic acid and pantethine; vitamins |
| 07/03/2003 | US20030124695 Genes encoding baeyer-villiger monooxygenases |
| 07/03/2003 | US20030124690 Novel compounds |
| 07/03/2003 | US20030124689 Mitomycin biosynthetic gene cluster |
| 07/03/2003 | US20030124687 LysE proteins; fermentation; animal feeds; dihydrodipicolinate synthases; amino acid biosynthesis |
| 07/03/2003 | US20030124686 Method for producing L-arginine |
| 07/03/2003 | US20030124684 Method for producing gamma-glutamylcysteine |
| 07/03/2003 | US20030124683 Comprises hydrolase for N-benzylazetidine-2-carboxylic acid ester immolbilized on poroous divinylbenzene-styrene copolymer |
| 07/03/2003 | US20030124682 Fermenting vitamin b5 for use in animal feeds; nutrients; peptidase B; decarboxylases; transferases; synthetases |
| 07/03/2003 | US20030124681 Process for the preparation of D-pantothenic acid and/or salts thereof |
| 07/03/2003 | US20030124680 Genetic engineering of polyketide synthases; erythromycins; drug screening and delivery |
| 07/03/2003 | US20030124678 Interleukin-2 mutants with reduced toxicity |
| 07/03/2003 | US20030124677 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 07/03/2003 | US20030124675 Isolated CDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA |
| 07/03/2003 | US20030124671 Somatomedins; kringle domains; antitumor agents; antiproliferative agents |
| 07/03/2003 | US20030124670 Analgesics; antinociceptive agents; antiinflammatory agents; antidiabbetic agents; diagnosing pain disorders |
| 07/03/2003 | US20030124668 Plasmid for use in gene expression, mapping and mutagenesis; transposases |
| 07/03/2003 | US20030124664 Aminopeptidase |
| 07/03/2003 | US20030124662 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | US20030124658 Molecular display on multmeric protein scaffolds derived from the e2 component of the alphaketoacid dehydrogenase |
| 07/03/2003 | US20030124655 Receptor protein specifically recognizing bacterial dna |
| 07/03/2003 | US20030124649 Membrane associated proteins |
| 07/03/2003 | US20030124648 Vector/plasmid for efficient and accurate transfer of preferential gene to rodent cells; glutamine synthetases |
| 07/03/2003 | US20030124645 Practical in vitro sialylation of recombinant glycoproteins |
| 07/03/2003 | US20030124629 Methods of detecting a cell |
| 07/03/2003 | US20030124626 Method of screening antiplatelet |
| 07/03/2003 | US20030124625 Novel interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding |
| 07/03/2003 | US20030124617 Antiinflammatory agents; antiarthritic agents; interleukins; antiallergens; bronchodilator agents |
| 07/03/2003 | US20030124614 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof |
| 07/03/2003 | US20030124608 Polymorphisms detected by hybridization of oligonucleotides with a nucleic acid derived from the fish |
| 07/03/2003 | US20030124607 Methods related to streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 07/03/2003 | US20030124603 Exocrine gland tight junction-constituting protein jeap family |
| 07/03/2003 | US20030124602 Tumour suppresor and uses thereof |
| 07/03/2003 | US20030124601 Oligonucleotide hybridizable with given gene regions; primers; measuring fluorescence |
| 07/03/2003 | US20030124600 Determining methylation ratio of a promoter region of glutathione-S-transferase relative to the level in a reference gene; polymerase chain reaction |
| 07/03/2003 | US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 07/03/2003 | US20030124597 Compositions and methods for identifying agents which regulate autolytic processes in bacteria |
| 07/03/2003 | US20030124596 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 07/03/2003 | US20030124593 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 07/03/2003 | US20030124592 Identifying a nucleic acid molecule or gene by hybridizing with a primer; detecting change in a parameter |
| 07/03/2003 | US20030124586 In vitro sorting method |
| 07/03/2003 | US20030124584 Methods for detecting genetic mosaicisms using arrays |
| 07/03/2003 | US20030124583 Solid matrix carrier; surface is subdivided for binding different analytes; use in diagnostics |
| 07/03/2003 | US20030124582 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
| 07/03/2003 | US20030124578 Assay for detection of human parvovirus B19 nucleic acid |
| 07/03/2003 | US20030124576 Such as (3-cyanocoumarinyl)dideoxyadenosine-5'-triphosphate which reacts with phosophatase to create detectable species (chemiluminescence, fluorescence); substrates for nucleic acid polymerases |
| 07/03/2003 | US20030124575 Dendritic cells; antigen presenting cells; g-protein coupled receptors; immunotherapy; antiinflammatory agents; antitumor agents; viricides; drug screening |
| 07/03/2003 | US20030124570 Methods for screening for proteins comprising a signal sequence |
| 07/03/2003 | US20030124567 Use of a leptospire protein preventing and/or diagnosing and/or treating animal or human leptospirosis |
| 07/03/2003 | US20030124565 Efficient methods for assessing and validating ecandidate protein-based therapeutic molecules encoded by nucleic acid sequences of interest |
| 07/03/2003 | US20030124563 Immunohistochemistry; tumor diagnosis; antitumor agents; anticarcinogenic agents; tissue engineering; ki-67 proteins |
| 07/03/2003 | US20030124562 Methods and compositions for producing full length cDNA libraries |
| 07/03/2003 | US20030124561 Plant centromere compositions |
| 07/03/2003 | US20030124559 Rna polymerases from bacteriophage phi 6-phI 14 and use thereof |
| 07/03/2003 | US20030124557 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| 07/03/2003 | US20030124556 Detecting bacteria or viral nucleotide sequences; restriction fragment length polymorphism; fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS); ion trap; time of flight |
| 07/03/2003 | US20030124555 Compositions and methods for use in isolation of nucleic acid molecules |
| 07/03/2003 | US20030124553 Skin treatment |
| 07/03/2003 | US20030124550 Method of screening drug for hepatitis C |
| 07/03/2003 | US20030124549 Devices and methods for detecting genetic sequences |
| 07/03/2003 | US20030124548 Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes |
| 07/03/2003 | US20030124546 Fragments of nucleic acids specific to mycobacteria which are members of the M. tuberculosis complex and their applications for the detection and the differential diagnosis of members of the M. tuberculosis complex |
| 07/03/2003 | US20030124544 Method for testing nucleic acid sequence |
| 07/03/2003 | US20030124540 Interventions to mimic the effects of calorie restriction |
| 07/03/2003 | US20030124538 Reverse two-hybrid systems |